Ação Alterar Data
Amgen USD 6.39B 169M 2026-09
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
Baxter International USD 2.3B 41M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Enviri Corporation USD 173.28M 7.27M 2026-03
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Glaxosmithkline GBP 6.3B 143M 2026-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 163.95M 21.56M 2026-09
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 14.51M 4.24M 2026-09
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.16B 43M 2026-09
Pfizer USD 10.02B 77M 2026-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Veracyte USD 25.82M 3.16M 2026-09